Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammation01:38

Inflammation

62.0K
Overview
62.0K
What is the Immune System?01:38

What is the Immune System?

127.7K
Overview
127.7K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

636
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
636
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.3K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.3K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

871
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
871
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.8K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The SHH/GLI target Netrin-1 supports self-renewal in medulloblastoma tumor cells.

Cell communication and signaling : CCS·2026
Same author

Induction of cardiac fibulin-4 protects against pressure overload-induced cardiac hypertrophy and heart failure.

Communications biology·2025
Same author

Differentiating Separate Primary Lung Adenocarcinomas From Intrapulmonary Metastases With Emphasis on Pathological and Molecular Considerations: Recommendations From the International Association for the Study of Lung Cancer Pathology Committee.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2024
Same author

Radiological follow-up in patients with resected pulmonary carcinoids: Should we reduce radiation exposure?

Lung cancer (Amsterdam, Netherlands)·2024
Same author

Clinical implications of nintedanib pharmacokinetics in patients with pulmonary fibrosis.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2024
Same author

Artificial intelligence-based recurrence prediction outperforms classical histopathological methods in pulmonary adenocarcinoma biopsies.

Lung cancer (Amsterdam, Netherlands)·2023

Related Experiment Video

Updated: Jan 30, 2026

Isolation, Characterization and Functional Examination of the Gingival Immune Cell Network
05:07

Isolation, Characterization and Functional Examination of the Gingival Immune Cell Network

Published on: February 16, 2016

11.4K

Inflammation and immunity in IPF pathogenesis and treatment.

P Heukels1, C C Moor2, J H von der Thüsen3

  • 1Department of Pulmonary Medicine, Erasmus Medical Centre, Rotterdam, the Netherlands; Department of Pulmonary Medicine, Amphia Hospital Breda, Breda, the Netherlands.

Respiratory Medicine
|February 2, 2019
PubMed
Summary

Idiopathic pulmonary fibrosis (IPF) involves immune responses in its progression. Understanding these immune mechanisms is key to developing new therapies for this fatal lung disease.

Keywords:
Idiopathic pulmonary fibrosisImmunityInflammationTreatmentTrials

More Related Videos

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut
10:05

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut

Published on: May 24, 2011

16.9K
Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
07:50

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

14.8K

Related Experiment Videos

Last Updated: Jan 30, 2026

Isolation, Characterization and Functional Examination of the Gingival Immune Cell Network
05:07

Isolation, Characterization and Functional Examination of the Gingival Immune Cell Network

Published on: February 16, 2016

11.4K
Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut
10:05

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut

Published on: May 24, 2011

16.9K
Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
07:50

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

14.8K

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Fibrosis Research

Background:

  • Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease marked by excessive extracellular matrix deposition.
  • Repetitive lung injury and impaired repair lead to progressive fibrosis in IPF.
  • Immune responses are present in all stages of IPF, though their role is debated.

Purpose of the Study:

  • To review the role of innate and adaptive immune systems in IPF pathobiology.
  • To discuss how current anti-fibrotic drugs affect immune responses in IPF.
  • To provide an overview of emerging immunomodulatory therapies for IPF.

Main Methods:

  • Literature review focusing on immune system involvement in IPF.
  • Analysis of current understanding of immune cell interactions in fibrosis.
  • Summary of clinical trials targeting immune pathways in IPF.

Main Results:

  • New insights highlight the roles of macrophages, T-cells, and B-cells in IPF.
  • Immune cells interact with (myo)fibroblasts, contributing to tissue remodeling.
  • Existing treatments like pirfenidone and nintedanib influence immune responses.

Conclusions:

  • The immune system plays a critical role in IPF initiation and progression.
  • Further research integrating immune mechanisms is needed for novel IPF therapies.
  • Targeting immune modulation presents a promising therapeutic strategy for IPF patients.